<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal CancerChristos S. Karapetis, John Zalcberg, Shirin Khambata‐Ford et al.|New England Journal of Medicine|2008Cited by 3.6k
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon CancerChristine Ribic, Steven Gallinger, Daniel J. Sargent et al.|New England Journal of Medicine|2003Cited by 2.1k
All-<i>trans</i>-Retinoic Acid in Acute Promyelocytic LeukemiaMartin S. Tallman, Peter H. Wiernik, Janet W. Andersen et al.|New England Journal of Medicine|1997Cited by 1.1k
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphomaChristopher Rushton, Ryan D. Morin, Sarah E. Arthur et al.|Blood Advances|2020Cited by 120
Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell LymphomaLaura K. Hilton, David W. Scott, Henry S. Ngu et al.|Journal of Clinical Oncology|2023Cited by 50